001     291272
005     20250729140537.0
024 7 _ |a 10.1002/ijc.35046
|2 doi
024 7 _ |a pmid:38924078
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:165084118
|2 altmetric
037 _ _ |a DKFZ-2024-01355
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Corradi, Chiara
|0 0000-0001-6216-9803
|b 0
245 _ _ |a Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk.
260 _ _ |a Bognor Regis
|c 2024
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1727782266_26628
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:C055# / 2024 Oct 15;155(8):1432-1442
520 _ _ |a Correlated regions of systemic interindividual variation (CoRSIV) represent a small proportion of the human genome showing DNA methylation patterns that are the same in all human tissues, are different among individuals, and are partially regulated by genetic variants in cis. In this study we aimed at investigating single-nucleotide polymorphisms (SNPs) within CoRSIVs and their involvement with pancreatic ductal adenocarcinoma (PDAC) risk. We analyzed 29,099 CoRSIV-SNPs and 133,615 CoRSIV-mQTLs in 14,394 cases and 247,022 controls of European and Asian descent. We observed that the A allele of the rs2976395 SNP was associated with increased PDAC risk in Europeans (p = 2.81 × 10-5). This SNP lies in the prostate stem cell antigen gene and is in perfect linkage disequilibrium with a variant (rs2294008) that has been reported to be associated with risk of many other cancer types. The A allele is associated with the DNA methylation level of the gene according to the PanCan-meQTL database and with overexpression according to QTLbase. The expression of the gene has been observed to be deregulated in many tumors of the gastrointestinal tract including pancreatic cancer; however, functional studies are needed to elucidate the function relevance of the association.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a DNA methylation
|2 Other
650 _ 7 |a pancreatic cancer
|2 Other
650 _ 7 |a risk factors
|2 Other
650 _ 7 |a single‐nucleotide polymorphism
|2 Other
700 1 _ |a Lencioni, Giulia
|b 1
700 1 _ |a Felici, Alessio
|b 2
700 1 _ |a Rizzato, Cosmeri
|0 0000-0002-7830-2178
|b 3
700 1 _ |a Gentiluomo, Manuel
|b 4
700 1 _ |a Ermini, Stefano
|b 5
700 1 _ |a Archibugi, Livia
|b 6
700 1 _ |a Mickevicius, Antanas
|b 7
700 1 _ |a Lucchesi, Maurizio
|b 8
700 1 _ |a Malecka-Wojciesko, Ewa
|b 9
700 1 _ |a Basso, Daniela
|b 10
700 1 _ |a Arcidiacono, Paolo Giorgio
|b 11
700 1 _ |a Petrone, Maria Chiara
|b 12
700 1 _ |a Carrara, Silvia
|b 13
700 1 _ |a Götz, Mara
|b 14
700 1 _ |a Bunduc, Stefania
|b 15
700 1 _ |a Holleczek, Bernd
|b 16
700 1 _ |a Aoki, Mateus Nóbrega
|b 17
700 1 _ |a Uzunoglu, Faik G
|b 18
700 1 _ |a Zanette, Dalila Lucíola
|b 19
700 1 _ |a Mambrini, Andrea
|b 20
700 1 _ |a Jamroziak, Krzysztof
|b 21
700 1 _ |a Oliverius, Martin
|b 22
700 1 _ |a Lovecek, Martin
|b 23
700 1 _ |a Cavestro, Giulia Martina
|b 24
700 1 _ |a Milanetto, Anna Caterina
|b 25
700 1 _ |a Peduzzi, Giulia
|b 26
700 1 _ |a Duchonova, Beatrice Mohelnikova
|b 27
700 1 _ |a Izbicki, Jakob R
|b 28
700 1 _ |a Zalinkevicius, Rimantas
|b 29
700 1 _ |a Hlavac, Viktor
|b 30
700 1 _ |a van Eijck, Casper H J
|b 31
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 32
|u dkfz
700 1 _ |a Vanella, Giuseppe
|b 33
700 1 _ |a Vokacova, Klara
|b 34
700 1 _ |a Soucek, Pavel
|b 35
700 1 _ |a Tavano, Francesca
|0 0000-0002-8831-7349
|b 36
700 1 _ |a Perri, Francesco
|b 37
700 1 _ |a Capurso, Gabriele
|b 38
700 1 _ |a Hussein, Tamás
|b 39
700 1 _ |a Kiudelis, Mindaugas
|b 40
700 1 _ |a Kupcinskas, Juozas
|b 41
700 1 _ |a Busch, Olivier R
|b 42
700 1 _ |a Morelli, Luca
|b 43
700 1 _ |a Theodoropoulos, George E
|b 44
700 1 _ |a Testoni, Sabrina Gloria Giulia
|b 45
700 1 _ |a Adamonis, Kestutis
|b 46
700 1 _ |a Neoptolemos, John P
|b 47
700 1 _ |a Gazouli, Maria
|0 0000-0002-3295-6811
|b 48
700 1 _ |a Pasquali, Claudio
|b 49
700 1 _ |a Kormos, Zita
|b 50
700 1 _ |a Skalicky, Pavel
|b 51
700 1 _ |a Pezzilli, Raffaele
|b 52
700 1 _ |a Sperti, Cosimo
|b 53
700 1 _ |a Kauffmann, Emanuele
|b 54
700 1 _ |a Büchler, Markus W
|b 55
700 1 _ |a Schöttker, Ben
|0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
|b 56
|u dkfz
700 1 _ |a Hegyi, Péter
|b 57
700 1 _ |a Capretti, Giovanni
|b 58
700 1 _ |a Lawlor, Rita T
|b 59
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 60
|e Last author
|u dkfz
700 1 _ |a Campa, Daniele
|0 0000-0003-3220-9944
|b 61
773 _ _ |a 10.1002/ijc.35046
|g p. ijc.35046
|0 PERI:(DE-600)1474822-8
|n 8
|p 1432-1442
|t International journal of cancer
|v 155
|y 2024
|x 0020-7136
856 4 _ |u https://inrepo02.dkfz.de/record/291272/files/Intl%20Journal%20of%20Cancer%20-%202024%20-%20Corradi%20-%20Potential%20association%20between%20PSCA%20rs2976395%20functional%20variant%20and%20pancreatic.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/291272/files/Intl%20Journal%20of%20Cancer%20-%202024%20-%20Corradi%20-%20Potential%20association%20between%20PSCA%20rs2976395%20functional%20variant%20and%20pancreatic.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:inrepo02.dkfz.de:291272
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 56
|6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 60
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2022
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2022
|d 2023-10-21
920 2 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21